Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

1.

Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: a multilevel model.

Vellinga A, Tansey S, Hanahoe B, Bennett K, Murphy AW, Cormican M.

J Antimicrob Chemother. 2012 Oct;67(10):2523-30. doi: 10.1093/jac/dks222. Epub 2012 Jun 22.

2.

Increasing prevalence of ESBL production among Irish clinical Enterobacteriaceae from 2004 to 2008: an observational study.

Fennell J, Vellinga A, Hanahoe B, Morris D, Boyle F, Higgins F, Lyons M, O'Connell K, Keady D, Cormican M.

BMC Infect Dis. 2012 May 15;12:116. doi: 10.1186/1471-2334-12-116.

3.

Antimicrobial management and appropriateness of treatment of urinary tract infection in general practice in Ireland.

Vellinga A, Cormican M, Hanahoe B, Bennett K, Murphy AW.

BMC Fam Pract. 2011 Oct 3;12(1):108.

4.

Opt-out as an acceptable method of obtaining consent in medical research: a short report.

Vellinga A, Cormican M, Hanahoe B, Bennett K, Murphy AW.

BMC Med Res Methodol. 2011 Apr 6;11:40. doi: 10.1186/1471-2288-11-40.

5.

Antifungal susceptibility testing and candidaemia at a tertiary referral hospital.

O'Connell K, Lyons M, Hanahoe B, Cormican M.

Ir Med J. 2011 Feb;104(2):55-6.

PMID:
21465880
6.

Prevalence of antenatal hepatitis B virus carriage in the west of Ireland.

O'Connell K, Cormican M, Hanahoe B, Smyth B.

Ir Med J. 2010 Mar;103(3):91-2. No abstract available.

PMID:
20669386
7.

Predictive value of antimicrobial susceptibility from previous urinary tract infection in the treatment of re-infection.

Vellinga A, Cormican M, Hanahoe B, Murphy AW.

Br J Gen Pract. 2010 Jul;60(576):511-3. doi: 10.3399/bjgp10X514765.

8.

A multilevel analysis of trimethoprim and ciprofloxacin prescribing and resistance of uropathogenic Escherichia coli in general practice.

Vellinga A, Murphy AW, Hanahoe B, Bennett K, Cormican M.

J Antimicrob Chemother. 2010 Jul;65(7):1514-20. doi: 10.1093/jac/dkq149. Epub 2010 May 10.

9.

Temporal and spatial distribution of human cryptosporidiosis in the west of Ireland 2004-2007.

Callaghan M, Cormican M, Prendergast M, Pelly H, Cloughley R, Hanahoe B, O'Donovan D.

Int J Health Geogr. 2009 Nov 24;8:64. doi: 10.1186/1476-072X-8-64.

10.

CTX-M enzymes are the predominant extended-spectrum beta-lactamases produced by Enterobacteriaceae in Ireland.

Morris D, Boyle F, Buckley V, Xu L, Hanahoe B, Hawkey P, Cormican M.

J Antimicrob Chemother. 2009 Oct;64(4):864-6. doi: 10.1093/jac/dkp297. Epub 2009 Aug 21. No abstract available.

11.

Linezolid resistant enterococcus faecium.

McNicholas S, Hanahoe B, Higgins F, McAnena O, Corbett-Feeney G, Cormican M.

Ir Med J. 2008 Jul-Aug;101(7):225-6. No abstract available.

PMID:
18810787
12.

A large outbreak of cryptosporidiosis in western Ireland linked to public water supply: a preliminary report.

Pelly H, Cormican M, O'Donovan D, Chalmers RM, Hanahoe B, Cloughley R, McKeown P, Corbett-Feeney G.

Euro Surveill. 2007 May 3;12(5):E070503.3. No abstract available.

13.

Outbreak of extended spectrum beta-lactamase producing E. coli in a nursing home in Ireland, May 2006.

Pelly H, Morris D, O'Connell E, Hanahoe B, Chambers C, Biernacka K, Gray S, Cormican M.

Euro Surveill. 2006 Aug 31;11(8):E060831.1. No abstract available.

PMID:
16966793
14.

A qualitative study of factors influencing antimicrobial prescribing by non-consultant hospital doctors.

De Souza V, MacFarlane A, Murphy AW, Hanahoe B, Barber A, Cormican M.

J Antimicrob Chemother. 2006 Oct;58(4):840-3. Epub 2006 Aug 2.

15.

Comparison of BACTEC MGIT 960 and BACTEC 460 for culture of Mycobacteria.

Whyte T, Cormican M, Hanahoe B, Doran G, Collins T, Corbett-Feeney G.

Diagn Microbiol Infect Dis. 2000 Oct;38(2):123-6.

PMID:
11035245
16.

Evaluation of the BACTEC MGIT 960 and MB BAC/T systems for routine detection of Mycobacterium tuberculosis.

Whyte T, Hanahoe B, Collins T, Corbett-Feeney G, Cormican M.

J Clin Microbiol. 2000 Aug;38(8):3131-2. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk